Cases 31 - 40 of 830
BAYER INTELLECTUAL PROPERTY GMBH et al v. MANKIND PHARMA LIMITED
as 2:2022cv05599
Plaintiff:
BAYER INTELLECTUAL PROPERTY GMBH, BAYER AG and JANSSEN PHARMACEUTICALS, INC.
Defendant:
MANKIND PHARMA LIMITED
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
BAYER INTELLECTUAL PROPERTY GMBH et al v. USV PRIVATE LIMITED
as 2:2022cv05485
Plaintiff:
BAYER INTELLECTUAL PROPERTY GMBH, BAYER PHARMA AG, BAYER AG and others
Defendant:
USV PRIVATE LIMITED
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
BAYER INTELLECTUAL PROPERTY GMBH et al v. USV PRIVATE LIMITED
as 3:2022cv05485
Plaintiff:
BAYER INTELLECTUAL PROPERTY GMBH, BAYER PHARMA AG, BAYER AG and others
Defendant:
USV PRIVATE LIMITED
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
BAYER INTELLECTUAL PROPERTY GMBH et al v. CHANGZHOU PHARMACEUTICAL FACTORY
as 2:2022cv02089
Plaintiff:
BAYER INTELLECTUAL PROPERTY GMBH, BAYER AG and JANSSEN PHARMACEUTICALS, INC.
Defendant:
CHANGZHOU PHARMACEUTICAL FACTORY
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
KHARAEVA et al v. BAYER AG et al
as 2:2022cv00640
Plaintiff:
ANNA KHARAEVA and ZSAIAHNA HUFF
Defendant:
BAYER AG, BAYER HEALTHCARE LLC and BAYER CORPORATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Bayer Pharma AG et al v. Micro Labs Ltd. et al
as 1:2022cv00165
Counter Defendant:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Counter Claimant:
Micro Labs Ltd. and Micro Labs USA Inc.
Cause Of Action: 35 U.S.C. § 271
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
as 1:2021md03017
In Re:
Xarelto (Rivaroxaban) ('310) Patent Litigation
Not Classified By Court:
Clerk of MDL Panel, Lupin Limited, Lupin Pharmaceuticals, Inc. and others
Counter Defendant:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Pharma AG et al v. Mylan Pharmaceuticals Inc. et al
as 1:2021cv01742
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals Inc.
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271
Bayer Pharma AG et al v. Taro Pharmaceutical Industries Ltd. et al
as 1:2021cv01000
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.
Cause Of Action: 35 U.S.C. § 271
Bayer Pharma AG et al v. Teva Pharmaceuticals USA, Inc.
as 1:2021cv01001
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
